Healthcare Costs of Post-Prostate Biopsy Sepsis Article Report uri icon

Overview

MeSH Major

  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Outcome Assessment (Health Care)
  • Patient Satisfaction
  • Quality of Life

abstract

  • © 2019 Elsevier Inc. Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.

publication date

  • January 2019

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2019.06.011

PubMed ID

  • 31229516

Additional Document Info